Potential time benefit in the assessment of recurrent rat rhabdomyosarcoma using positron emission tomography (PET) with 18fluorodeoxyglucose depends on therapy-specific growth delay

Strahlentherapie und Onkologie

Volumn 182, Issue 10, 2006, Pages 610-615

  Raabe, Annette ^a   Buchert, Ralph ^a   Seegers, Barbara ^a   De Wit, Maike ^a  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

Author keywords

18FDG PET; Growth delay; Rat rhabdomyosarcoma R1H; Recurrence; Time benefit; Tumor bed effect

Indexed keywords

DOXORUBICIN; FLUORODEOXYGLUCOSE F 18; IFOSFAMIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER CHEMOTHERAPY; CANCER GROWTH; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SURGERY; CONTROLLED STUDY; CORRELATION ANALYSIS; MULTIMODALITY CANCER THERAPY; MUSCLE RESECTION; NONHUMAN; POSITRON EMISSION TOMOGRAPHY; RAT; RHABDOMYOSARCOMA; TIME; TREATMENT OUTCOME; TUMOR VOLUME; WHOLE BODY SCANNER;

ANIMALS; FEASIBILITY STUDIES; FLUORODEOXYGLUCOSE F18; NEOPLASM RECURRENCE, LOCAL; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; RATS; REPRODUCIBILITY OF RESULTS; RHABDOMYOSARCOMA; SENSITIVITY AND SPECIFICITY; TIME FACTORS;

EID: 33749248033     PISSN: 01797158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00066-006-1553-5     Document Type: Article

References (28)

1. Baumann M, Würschmidt F, Twardy A, et al. Impact of tumor stroma on expression of the tumor bed effect in R1H rhabdomyosarcoma. Radiat Res 1994;140:432-6.
2. Beck-Bornholdt H-P, Maurer T, Becker S, et al. Radiotherapy of the rhabdomyosarcoma R1H of the rat: hyperfractionation - 126 fractions applied within 6 weeks. Int J Radiat Oncol Biol Phys 1989;16:701-5.
3. Carl UM, Beck-Bornholdt HP, Baumann M, et al. Radiotherapy of the rhabdomyosarcoma R1H of the rat: postoperative radiotherapy. Int J Radiat Oncol Biol Phys 1990;18:883-6.
4. Clifton KH, Jirtle MS. Mammary carcinoma cell population growth in preirradiated and unirradiated transplant sites. Viable tumor growth, vascularity, and the tumor-bed effect. Radiology 1975;117:459-65.
5. 18fluorodeoxyglucose. Int J Radiat Biol 2004;80:529-39.
6. De Wit M, Raabe A, Tuinmann G, et al. Implantable device for intravenous drug delivery in the rat. Lab Anim 2001;35:321-4.
7. Frankl O, Kimball CP. Über die Beeinflussung von Mäusetumoren durch Röntgenstrahlen. Wien Klin Wochenschrift 1914;45:1448-50.
8. 18F]-2-Fluoro-2′-Deoxyglucose). An appraisal of radiotherapeutically relevant hypoxia. Strahlenther Onkol 2004;180:616-22.
9. Grosu AL, Piert M, Weber WA, et al. Positron emission tomography for radiation treatment planning. Strahlenther Onkol 2005;181:483-99.
10. Jung H, Beck H-P, Brammer I, et al. Depopulation and repopulation of the R1H-rhabdomyosarcoma of the rat after x-irradiation. Eur J Cancer 1981;17:375-86.
11. Jung H, Krüger HJ, Brammer I, et al. Cell population kinetics of the rhabdomyosarcoma R1H of the rat after single dose of X-rays. Int J Radiat Oncol Biol 1990;57:567-89.
12. Kim IH, Lemmon MJ, Brown JM. The influence of irradiation of the tumor bed on tumor hypoxia: measurements by radiation response, oxygen electrodes, and nitroimidazole binding. Radiat Res 1993;135:411-7.
13. Menzel C Döbert N, Hamscho N, et al. The influence of CA 125 and CEA levels on the results of (18)F-deoxyglucose positron emission tomography in suspected recurrence of epithelial ovarian cancer. Strahlenther Onkol 2004;180:497-501.
14. Milas L, Hunter N, Peters LJ. Tumor bed effect-induced reduction of tumor radiocurability through the increase in hypoxic cell fraction. Int J Radiat Oncol Biol Phys 1989;16:139-42.
15. Minn H, Leskinen-Kallio S, Lindholm P, et al. (18-F) fluorodeoxyglucose uptake in tumors: kinetic vs. steady-state methods with reference to plasma insulin. J Comput Assist Tomogr 1993;17:115-23.
16. Okunieff P, Dols S, Lee J, et al. Angiogenesis determines blood flow, metabolism, growth rate, and ATPase kinetics of tumors growing in an irradiated bed: 31P and 2H nuclear magnetic resonance studies. Cancer Res 1991;51:3289-95.
17. Penhaligon M, Courtenay VD, Camplejohn RS. Tumour bed effect: hypoxic fraction of tuours growing in preirradiated beds. Int J Radiat Oncol Relat Stud Phys Chem Med 1987;52:635-41.
18. Raabe A, Beck-Bornholdt H-P. Radiobiological determination of growth kinetics and radiosensitivity of pulmonary micrometastases of the R1H tumour. Radiother Oncol 1994;30:254-62.
19. Raabe A, Gottschalk A, Hommel M, et al. No effect of the hemoglobin solution HBOC-201 on the response of the rat R1H-tumor to fractionated irradiation. Strahlenther Onkol 2005;181:730-7.
20. Raabe A, Quaester S, Dubben H-H, et al. Impact of treatment acceleration and its timing on the response of the rhabdomyosarcoma R1H of the rat to fractionated irradiation. Strahlenther Onkol 2001;177:362-6.
21. Rofstad EK, Mathiesen B, Henriksen K, et al. The tumor bed effect: increased metastatic dissemination from hypoxic-induced up-regulation of metastatis-promoting gene products. Cancer Res 2005;65:2387-96.
22. Saeki Y, Shimazaki S, Urano M. Radiation effect on the vascularization of a C3H mouse mammary carcinoma. Microangiograhic studies of the tumor in preirradiated tissue and of the recurrent tumor. Radiology 1971;101:175-80.
23. Strauss LG. Fluorine-18 deoxyglucose and false positive results: a major problem in the diagnostics of oncological patients. Eur J Nucl Med 1996;23:1409-15.
24. Tatsumi M, Nakamoto Y, Traughber B, et al. Initial experience in small animal tumor imaging with a clinical positron emission tomography/computed tomography scanner using 2-[F-18]fluoro-2-desoxy-D-glucose. Cancer Res 2003;63:6252-7.
25. Vogler H, Beck-Bornholdt H-P. Radiotherapy of the rhabdomyosarcoma R1H of the rat: kinetics of cellular inactivation by fractionated irradiation. Int J Radiat Oncol Biol Phys 1988;14:317-25.
26. Würschmidt F, Beck-Bornholdt H-P, Vogler H. Radiobiology of the rhabdomyosarcoma R1H of the rat: influence of the size of irradiation field on tumor response, tumor bed effect, and neovascularization kinetics. Int J Radiat Oncol Biol Phys 1990;18:879-82.
27. Würschmidt F, Beck-Bornholdt H-P, Vogler H, et al. Radiotherapy of the rhabdomyosarcoma R1H of the rat: split-course versus continuous fractionation. Strahlenther Onkol 1991;167:26-30.
28. Zips D, Eicheler W, Brüchner K, et al. Impact of the tumour bed effect on microenvironment radiobiological hypoxia and the outcome of fractionated radiotherapy of human FaDu squamous-cell carcinoma growing in the nude mouse. Int J Radiat Biol 2001;77:1185-93.